CTRI/2018/06/014605尚未招募不适用
prevalence of different types of Skin diseases in school going children
Ayothidoss pandithar hospital national institute of siddha tambaram sanatorium chennai1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2018年6月22日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- To evaluate the prevalence of different types of Skin diseases in school going children
研究概览
简要总结
It is a non randomized cross sectional, observational study to evaluate the Prevalence of different types of skin diseases in school going children.Total sample size of the study is 500.The study will be conducted at Ayothidoss Pandithar hospital,National Institute of siddha,Chennai.Outcome of the study will be assessed on the basis of Questionnaire
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6.00 Year(s) 至 12.00 Year(s)（—）
- 性别
- All
入选标准
- •Childrens those who are having different type of skin diseases such as Eczema,Vitiligo,Psoriasis,Scabis,Nutritional deficiency and Fungal infection.
排除标准
- •Childrens below 6 years and above 12 years.
结局指标
主要结局
To evaluate the prevalence of different types of Skin diseases in school going children
时间窗: 1 visit
次要结局
- To study the prevalence base on low economic status,Malnutrition ,Poor standards of hygiene(Zeroth day)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Study of Prevalence of EGFR Mutations in Participants With NSCLCNon-Small Cell Lung CancerNCT02695849Hoffmann-La Roche69
尚未招募
Unknown
Survey study on skin diseasesCTRI/2023/09/057596Parul institute of ayurved and research
尚未招募
Unknown
Study Of common skin diseases in old age people in rural area of DelhiCTRI/2023/10/058432Department of community medicine, Maulana Azad Medical College
已完成
不适用
Cross-sectional, Non-randomized Observational Study to Assess the Frequency of Reduced Sodium Intake in the Primary Care Setting - LAXAPDietary DeficiencySodiumNCT06121583Casen Recordati S.L.449
已完成
不适用
An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes PatientsDiabetesNCT02208921AstraZeneca3,000